Preclinical mouse solid tumour models: status quo, challenges and perspectives

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Reviews. Cancer

• Publication date

  2017-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc.2017.92PMID 29077691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2017

  2017cited by this paper
• Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer

  2017cited by this paper
• Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research.

  2017cited by this paper
• In vivo genome editing and organoid transplantation models of colorectal cancer

  2017cited by this paper
• Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice

  2017cited by this paper
• Announcement: Towards greater reproducibility for life-sciences research in Nature

  2017cited by this paper
• Emerging Biological Principles of Metastasis.

  2017cited by this paper
• Humanized Mouse Models of Clinical Disease.

  2017cited by this paper
• Interrogating open issues in cancer precision medicine with patient-derived xenografts

  2017cited by this paper
• Parsing clinical success rates

  2016cited by this paper
• Reproducibility: Respect your cells!

  2016cited by this paper
• Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

  2016cited by this paper
• Environmental risk factors for pancreatic cancer: an update

  2016cited by this paper
• CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

  2016cited by this paper
• Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice

  2016cited by this paper
• Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

  2016cited by this paper
• Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

  2016cited by this paper
• Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer

  2016cited by this paper
• Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes.

  2016cited by this paper
• Mouse models in oncoimmunology

  2016cited by this paper
• Reproducible pharmacogenomic profiling of cancer cell line panels

  2016cited by this paper
• Genetically engineered mouse models in oncology research and cancer medicine

  2016cited by this paper
• Discovery of Nigri/nox and Panto/pox site-specific recombinase systems facilitates advanced genome engineering

  2016cited by this paper
• Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy

  2016cited by this paper
• Optimizing mouse models for precision cancer prevention

  2016cited by this paper
• Biotech R&D spend jumps by more than 15%

  2016cited by this paper
• Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis

  2016cited by this paper
• A STAR Is Born.

  2016cited by this paper
• Amgen's angiopoietin blocker fails in ovarian cancer

  2015cited by this paper
• Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.

  2015cited by this paper
• Toward understanding and exploiting tumor heterogeneity

  2015cited by this paper
• Mouse hospital and co-clinical trial project—from bench to bedside

  2015cited by this paper
• Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma

  2015cited by this paper
• Induction of Lung Tumors in Mice with Urethane.

  2015cited by this paper
• HER2 activating mutations are targets for colorectal cancer treatment.

  2015cited by this paper
• Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer

  2015cited by this paper
• Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years.

  2015cited by this paper
• Tumorigenesis: it takes a village

  2015cited by this paper
• Applications of the CRISPR–Cas9 system in cancer biology

  2015cited by this paper
• Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern

  2015cited by this paper
• CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Organoid models of human and mouse ductal pancreatic cancer.

  2015cited by this paper
• XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer

  2015cited by this paper
• Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014

  2015cited by this paper
• Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours

  2015cited by this paper
• Prospective derivation of a living organoid biobank of colorectal cancer patients.

  2015cited by this paper
• Preclinical mouse cancer models: a maze of opportunities and challenges.

  2015cited by this paper
• Using the GEMM-ESC strategy to study gene function in mouse models

  2015cited by this paper
• A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment

  2015cited by this paper
• A Review of Current Animal Models for the Study of Cervical Dysplasia and Cervical Carcinoma

  2015cited by this paper
• Induction of Liver Tumors in Mice with N-Ethyl-N-Nitrosourea or N-Nitrosodiethylamine.

  2015cited by this paper
• High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

  2015cited by this paper
• Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods

  2015cited by this paper
• Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements.

  2015cited by this paper
• Concise Review: Humanized Models of Tumor Immunology in the 21st Century: Convergence of Cancer Research and Tissue Engineering

  2015cited by this paper
• A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

  2015cited by this paper
• Animal models of human colorectal cancer: Current status, uses and limitations.

  2015cited by this paper
• Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts

  2015cited by this paper
• Induction of Colon Cancer in Mice with 1,2-Dimethylhydrazine.

  2015cited by this paper
• Establishment of primary patient‐derived xenografts of palliative TURP specimens to study castrate‐resistant prostate cancer

  2015cited by this paper
• IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

  2015cited by this paper
• Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.

  2015cited by this paper
• Patient-derived xenograft models: an emerging platform for translational cancer research.

  2014cited by this paper
• An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.

  2014cited by this paper
• Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth.

  2014cited by this paper
• Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

  2014cited by this paper
• Current animal models of bladder cancer: Awareness of translatability (Review)

  2014cited by this paper
• Human cancer growth and therapy in immunodeficient mouse models.

  2014cited by this paper
• Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes.

  2014cited by this paper
• Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing

  2014cited by this paper
• Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution

  2014cited by this paper
• Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

  2014cited by this paper
• “Glowing Head” Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts

  2014cited by this paper
• One mouse, one patient paradigm: New avatars of personalized cancer therapy.

  2014cited by this paper
• Cells to surgery quiz: june 2014.

  2014cited by this paper
• Models: stretching the skills of cell lines and mice

  2014cited by this paper
• Milestones in skin carcinogenesis: the biology of multistage carcinogenesis.

  2014cited by this paper
• A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer

  2014cited by this paper
• Time to do something about reproducibility

  2014cited by this paper
• The mutational landscapes of genetic and chemical models of Kras-driven lung cancer

  2014cited by this paper
• Modelling bladder cancer in mice: opportunities and challenges

  2014cited by this paper
• Rebuilding cancer metastasis in the mouse

  2013cited by this paper
• Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer.

  2013cited by this paper
• Patient-derived tumor xenografts: transforming clinical samples into mouse models.

  2013cited by this paper
• Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.

  2013cited by this paper
• One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.

  2013cited by this paper
• Adjuvant gemcitabine therapy improves survival in a locally induced, R0‐resectable model of metastatic intrahepatic cholangiocarcinoma

  2013cited by this paper
• Development of orthotopic pancreatic tumor mouse models.

  2013cited by this paper
• Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics

  2013cited by this paper
• Patient-derived breast tumor xenografts facilitating personalized cancer therapy

  2013cited by this paper
• Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models

  2012cited by this paper
• A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

  2012cited by this paper
• In vivo evaluation of ΦC31 recombinase activity in transgenic mice.

  2012cited by this paper
• Associations between environmental factors and incidence of cutaneous melanoma. Review

  2012cited by this paper
• Understanding Waterfall Plots

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper

• Preclinical evaluation of FAP-targeted PET imaging to investigate CAF responses to radiotherapy.

  2026cites this paper
• Discovery of predictive biomarkers for cancer therapy through computational approaches

  2026cites this paper
• Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burden.

  2026cites this paper
• Tumor-on-Chip Platforms for Precision Oncology: Bridging Tumor Heterogeneity and Preclinical Drug Testing.

  2026cites this paper
• The application of experimental models for the drug discovery for digestive tumors.

  2026cites this paper
• Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusion

  2025cites this paper
• A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice

  2025cites this paper
• 3D Bioprinting for Engineering Organoids and Organ‐on‐a‐Chip: Developments and Applications

  2025cites this paper
• Minimally-Invasive Imaging of Sublingual Vessels—A New Method to Study Microvascular Changes in Mice

  2025cites this paper
• Exercise boost after surgery improves survival in model of metastatic breast cancer

  2025cites this paper
• Overcoming solid-tumor barriers: armored CAR-T cell therapy.

  2025cites this paper
• Immunological Tolerance to Luciferase and Fluorescent Proteins using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis.

  2025cites this paper
• A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors.

  2025cites this paper
• Direct genetic transformation bypasses tumor-associated DNA methylation alterations

  2025cites this paper
• Differential Assembly of Mouse and Human Tumor Microenvironments

  2025cites this paper
• Orthotopic pituitary tumors generated by stereotaxic GC cell injection in immunocompetent rats

  2025cites this paper
• Pancreatic organoids as cancer avatars for true personalized medicine.

  2025cites this paper
• Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis

  2025cites this paper
• Preclinical Models of Solid Cancers for Testing Cancer Immunotherapies

  2025cites this paper
• FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-In-Human Trials.

  2025cites this paper
• Multi-omics reveals that QKI-mediated NIN exon 18 splicing drives breast cancer cell progression.

  2025cites this paper
• Advances in microengineered platforms for 3D tumor production and modeling

  2025cites this paper
• Construction Of Multicellular Tumor-On-A-Chip Models for Ovarian Cancer Research

  2025cites this paper
• RNF20 links the DNA damage response and metabolic rewiring in lung cancer through HIF1α

  2025cites this paper
• Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer

  2025cites this paper
• Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies

  2025cites this paper
• TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model

  2025cites this paper
• Application and prospect analysis of chimeric antigen receptor T-cell therapy in hepatocellular carcinoma treatment: a systematic review and meta-analysis

  2025cites this paper
• Spontaneous and experimental models of lymph node metastasis

  2025cites this paper
• Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma

  2025cites this paper
• New insights into the role of complement system in colorectal cancer (Review)

  2025cites this paper
• C/Si Exchange Strategy for Enhanced Photothermal Therapy of Oral Squamous Cell Carcinoma

  2025cites this paper
• Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas

  2025cites this paper
• Emerging strategies to investigate the biology of early cancer

  2024cites this paper
• Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring

  2024cites this paper
• Cancer cell metabolism and antitumour immunity

  2024cites this paper
• Research Progress on Cyclic-Peptide Functionalized Nanoparticles for Tumor-Penetrating Delivery

  2024cites this paper
• Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response

  2024cites this paper
• Innovative Strategies in Regenerative Medicine: Bridging Science and Clinical Practice

  2024cites this paper
• Breast cancer spheroids prefer activated macrophages as an accomplice: An in vitro study

  2024cites this paper
• Multifaceted perspectives of detecting and targeting solid tumors.

  2024cites this paper
• Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity.

  2024cites this paper
• Vergleichende Pathologie in der onkologischen Forschung

  2024cites this paper
• Mechanoimmunology in the solid tumor microenvironment.

  2024cites this paper
• Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer

  2024cites this paper
• Impacts of tissue context on extracellular vesicles‐mediated cancer–host cell communications

  2024cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

  2024cites this paper
• Orthotopic and metastatic tumour models in preclinical cancer research

  2024cites this paper
• Hippo effector, Yorkie, is a tumor suppressor in select Drosophila squamous epithelia

  2024cites this paper
• Rebuilding the microenvironment of primary tumors in humans: a focus on stroma

  2024cites this paper
• Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer.

  2024cites this paper
• Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation

  2024cites this paper
• Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer

  2024cites this paper
• DNA origami-based nano-vaccines for cancer immunotherapy

  2024cites this paper
• Perioperative hypothermia and stress jeopardize antimetastatic immunity and TLR-9 immune activation: potential mediating mechanisms (experimental studies)

  2024cites this paper
• Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor

  2024cites this paper
• An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome

  2024cites this paper
• Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside

  2024cites this paper
• Viridibacillus culture derived silver nanoparticles exert potent anticancer action in 2D and 3D models of lung cancer via mitochondrial depolarization-mediated apoptosis

  2024cites this paper
• Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy.

  2024cites this paper
• Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts

  2024cites this paper
• Leveraging preclinical models of metastatic breast cancer.

  2024cites this paper
• Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer

  2024cites this paper
• Imaging the Tumor Antioxidant Response with [18F]FSPG PET.

  2024cites this paper
• Mechanisms of metastatic colorectal cancer

  2024cites this paper
• An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors

  2024cites this paper
• Dual Enzyme Cascade-Activated Popcorn-Like Nanoparticles Efficiently Remodeled Stellate Cells to Alleviate Pancreatic Desmoplasia.

  2023cites this paper
• Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development.

  2023cites this paper
• Breast Cancer Tissue Explants: An Approach to Develop Personalized Therapy in Public Health Services

  2023cites this paper
• A comprehensive review of animal models for cancer cachexia: Implications for translational research

  2023cites this paper
• Aberrant accumulation of NIK promotes tumor growth by dysregulating translation and post-translational modifications in breast cancer

  2023cites this paper
• Innovations in Cancer Treatment of Children

  2023cites this paper
• Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research

  2023cites this paper
• Location, location: understanding the metastatic microenvironment

  2023cites this paper
• Engineering Heterogeneous Tumor Models for Biomedical Applications

  2023cites this paper
• Immunotherapy during the Immediate Perioperative Period: A Promising Approach against Metastatic Disease

  2023cites this paper
• Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined in vivo model

  2023cites this paper
• Advancing translational research for colorectal immuno-oncology

  2023cites this paper
• Obesity and cancer: Mouse models used in studies

  2023cites this paper
• Fisheye piezo polymer detector for scanning optoacoustic angiography of experimental neoplasms

  2023cites this paper
• Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment

  2023cites this paper
• Effects of NM23 transfection of human gastric carcinoma cells in mice

  2023cites this paper
• pH-responsive dual-functional hydrogel integrating localized delivery and anti-cancer activities for highly effective therapy in PDX of OSCC

  2023cites this paper
• Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

  2023cites this paper
• New established cell lines from undifferentiated pleomorphic sarcoma for in vivo study

  2023cites this paper
• Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish

  2023cites this paper
• Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting.

  2023cites this paper
• Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies

  2023cites this paper
• Paraoxonase 2 (PON2) plays a limited role in murine lung tumorigenesis

  2023cites this paper
• Synergistic Effect of Co‐Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer Agents

  2023cites this paper
• An osteosarcoma-on-a-chip model for studying osteosarcoma matrix-cell interactions and drug responses

  2023cites this paper
• In Vivo Tumorigenicity Assays Using Subcutaneous and Orthotopic Xenografts in Immunodeficient Mice.

  2022cites this paper
• Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models

  2022cites this paper
• Issues and challenges to reproducibility of cancer research: a commentary.

  2022cites this paper
• Dormancy in cancer bone metastasis

  2022cites this paper
• Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling

  2022cites this paper
• A Genetically Encoded Magnetic Resonance Imaging Reporter Enables Sensitive Detection and Tracking of Spontaneous Metastases in Deep Tissues.

  2022cites this paper
• A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis

  2022cites this paper
• Roadmap for precision preclinical x-ray radiation studies

  2022cites this paper
• A human vascularized microtumor model of patient-derived colorectal cancer recapitulates clinical disease

  2022cites this paper